The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial Cancelled under Section 30(1)(c) of the Act
Product name
TEVIMBRA tislelizumab 100 mg/10 mL concentrated injection vial
Sponsor
ARTG
423470
Date of effect
Decision type
Cancelled under Section 30(1)(c) of the Act